242 related articles for article (PubMed ID: 10590503)
21. Transvenous atrial defibrillation--techniques and clinical applications.
Tse HF; Lau CP; Camm AJ
Clin Cardiol; 1999 Oct; 22(10):614-22. PubMed ID: 10526684
[TBL] [Abstract][Full Text] [Related]
22. Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: assessment of the electrophysiological effects by biatrial basket electrodes.
Lai LP; Lin JL; Lien WP; Tseng YZ; Huang SK
J Am Coll Cardiol; 2000 May; 35(6):1434-41. PubMed ID: 10807444
[TBL] [Abstract][Full Text] [Related]
23. Future directions of electrotherapy for atrial fibrillation.
Reuter D; Ayers GM
J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S202-10. PubMed ID: 9727698
[TBL] [Abstract][Full Text] [Related]
24. [How to do: Cardioversion].
Lewalter T; Jilek C
Dtsch Med Wochenschr; 2016 May; 141(10):706-8. PubMed ID: 27176064
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: a systematic review.
Kirkland S; Stiell I; AlShawabkeh T; Campbell S; Dickinson G; Rowe BH
Acad Emerg Med; 2014 Jul; 21(7):717-26. PubMed ID: 25117151
[TBL] [Abstract][Full Text] [Related]
26. Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study.
Okishige K; Nishizaki M; Azegami K; Igawa M; Yamawaki N; Aonuma K;
Am Heart J; 2000 Sep; 140(3):e13. PubMed ID: 10966544
[TBL] [Abstract][Full Text] [Related]
27. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.
Macchia A; Grancelli H; Varini S; Nul D; Laffaye N; Mariani J; Ferrante D; Badra R; Figal J; Ramos S; Tognoni G; Doval HC;
J Am Coll Cardiol; 2013 Jan; 61(4):463-468. PubMed ID: 23265344
[TBL] [Abstract][Full Text] [Related]
28. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
Hayashi M; Tanaka K; Kato T; Morita N; Sato N; Yasutake M; Kobayashi Y; Takano T
J Cardiovasc Electrophysiol; 2005 Jul; 16(7):740-7. PubMed ID: 16050832
[TBL] [Abstract][Full Text] [Related]
29. High energy transcatheter cardioversion of chronic atrial fibrillation.
Levy S; Lacombe P; Cointe R; Bru P
J Am Coll Cardiol; 1988 Aug; 12(2):514-8. PubMed ID: 3392346
[TBL] [Abstract][Full Text] [Related]
30. Internal atrial defibrillation - a new treatment of postoperative atrial fibrillation.
Liebold A; Haisch G; Rosada B; Kleine P
Thorac Cardiovasc Surg; 1998 Dec; 46(6):323-6. PubMed ID: 9928851
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the defibrillation threshold in atrial fibrillation by transoesophageal cardioversion using a biphasic impulse.
Prochaczek F; Winiarska H; Kończakowski P; Pyka R; Dziuk D; Gałecka J
Kardiol Pol; 2006 Apr; 64(4):373-9; discussion 380-2. PubMed ID: 16699980
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in the non-surgical management of atrial fibrillation.
Kamalvand K; Sulke N
Int J Clin Pract; 1999; 53(1):44-9. PubMed ID: 10344066
[TBL] [Abstract][Full Text] [Related]
33. Termination of Atrial Fibrillation With Epicardial Cooling in the Oblique Sinus.
Witt CM; Dalton S; O'Neil S; Ritrivi CA; Sanders R; Sharma A; Seifert G; Berhow S; Beinborn D; Witz A; McCaw T; Scott CG; Padmanabhan D; Killu AM; Naksuk N; Asirvatham SJ; Friedman PA
JACC Clin Electrophysiol; 2018 Oct; 4(10):1362-1368. PubMed ID: 30336883
[TBL] [Abstract][Full Text] [Related]
34. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
[TBL] [Abstract][Full Text] [Related]
35. Future prospects for implantable devices for atrial defibrillation.
Tse HF; Lau CP
Cardiol Clin; 2004 Feb; 22(1):87-100, ix. PubMed ID: 14994850
[TBL] [Abstract][Full Text] [Related]
36. Therapy of atrial fibrillation: rhythm control versus rate control.
Carlsson J; Neuzner J; Rosenberg YD
Pacing Clin Electrophysiol; 2000 May; 23(5):891-903. PubMed ID: 10833712
[No Abstract] [Full Text] [Related]
37. The future role of defibrillators in the management of atrial fibrillation.
Ayers GM; Griffin JC
Curr Opin Cardiol; 1997 Jan; 12(1):12-7. PubMed ID: 9132075
[TBL] [Abstract][Full Text] [Related]
38. Pharmacologic and Nonpharmacologic Management of Atrial Fibrillation.
Dahya V; Taigen TL
Med Clin North Am; 2019 Sep; 103(5):835-846. PubMed ID: 31378329
[TBL] [Abstract][Full Text] [Related]
39. Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results.
Lévy S; Ricard P; Gueunoun M; Yapo F; Trigano J; Mansouri C; Paganelli F
Circulation; 1997 Jul; 96(1):253-9. PubMed ID: 9236442
[TBL] [Abstract][Full Text] [Related]
40. Current management of symptomatic atrial fibrillation.
Haghi D; Schumacher B
Am J Cardiovasc Drugs; 2001; 1(2):127-39. PubMed ID: 14728042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
